Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 9

Results: 25

Blockade of the TIGIT-CD155/CD112 axis enhances functionality of NK-92 but not cytokine-induced memory-like NK cells toward CD155-expressing acute myeloid leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03766-7

By:

Seel, Katharina;
Schirrmann, Ronja Larissa;
Stowitschek, Daniel;
Ioseliani, Tamar;
Roiter, Lea;
Knierim, Alina;
André, Maya C.

Publication type:

Article

Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03764-9

By:

Wang, Zhenghang;
Cheng, Siyuan;
Yao, Yanhong;
Liu, Shengde;
Liu, Zimin;
Liu, Ning;
Jin, Yongdong;
Zhang, Yinjie;
Yin, Fei;
Han, Guangjie;
Zhang, Jingdong;
Wang, Qiwei;
Yan, Dong;
Wang, Li;
Lu, Hongxia;
Deng, Ting;
Ji, Zhi;
Gao, Hui;
Fang, Weijia;
Zhang, Hangyu

Publication type:

Article

In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03760-z

By:

Timmerman, Laura M.;
Hensen, Lobke C. M.;
van Eijs, Mick J. M.;
Verheijden, Rik J.;
Suijkerbuijk, Karijn P. M.;
Meyaard, Linde;
van der Vlist, Michiel;
Kuball, Jürgen H. E.;
Oldenburg, Bas;
Leusen, Jeanette H. W.

Publication type:

Article

Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03750-1

By:

Gawaz, A.;
Wolff, I.;
Nanz, L.;
Flatz, L.;
Forschner, A.

Publication type:

Article

Correction to: The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.

Published in:

2024

By:

Lu, Wenxin;
Wu, Guangyu;
Miao, Xianyuan;
Ma, Jingyu;
Wang, Yanling;
Xu, Haiyan;
Shentu, Daiyuan;
Xue, Shengbai;
Xia, Qing;
Wang, Yu;
Wang, Liwei

Publication type:

Correction Notice

Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.

Published in:

2024

By:

Jancewicz, Iga;
Śmiech, Magdalena;
Winiarska, Magdalena;
Zagozdzon, Radoslaw;
Wisniewski, Pawel

Publication type:

Correction Notice

TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03770-x

By:

Pearson, Joshua R. D.;
Puig-Saenz, Carles;
Thomas, Jubini E.;
Hardowar, Lydia D.;
Ahmad, Murrium;
Wainwright, Louise C.;
McVicar, Adam M.;
Brentville, Victoria A.;
Tinsley, Chris J.;
Pockley, A. Graham;
Durrant, Lindy G.;
McArdle, Stephanie E. B.

Publication type:

Article

A "Prime and Expand" strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03765-8

By:

Shrestha, Niraj;
Dee, Michael J.;
Chaturvedi, Pallavi;
Leclerc, Gilles M.;
Mathyer, Mary;
Dufour, Celeste;
Arthur, Laura;
Becker-Hapak, Michelle;
Foster, Mark;
McClain, Ethan;
Pena, Natalia Valderrama;
Kage, Karen;
Zhu, Xiaoyun;
George, Varghese;
Liu, Bai;
Egan, Jack;
Echeverri, Christian;
Wang, Meng;
You, Lijing;
Kong, Lin

Publication type:

Article

The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03763-w

By:

Wu, Julie Tsu-Yu;
Corrigan, June;
Su, Chloe;
Dumontier, Clark;
La, Jennifer;
Khan, Aparjita;
Arya, Shipra;
Harris, Alex H. S.;
Backhus, Leah;
Das, Millie;
Do, Nhan V.;
Brophy, Mary T.;
Han, Summer S.;
Kelley, Michael;
Fillmore, Nathanael R.

Publication type:

Article

Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03761-y

By:

Cheng, Chun-Chia;
Chang, Jungshan;
Ho, Ai-Sheng;
Sie, Zong-Lin;
Peng, Cheng-Liang;
Wang, Chih‑Liang;
Dev, Kapil;
Chang, Chun-Chao

Publication type:

Article

Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03759-6

By:

Chupradit, Koollawat;
Muneekaew, Saitong;
Wattanapanitch, Methichit

Publication type:

Article

γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03758-7

By:

Rodin, William;
Szeponik, Louis;
Rangelova, Tsvetanka;
Tamiru Kebede, Firaol;
Österlund, Tobias;
Sundström, Patrik;
Hogg, Stephen;
Wettergren, Yvonne;
Cosma, Antonio;
Ståhlberg, Anders;
Bexe Lindskog, Elinor;
Quiding Järbrink, Marianne

Publication type:

Article

Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03757-8

By:

Zhang, Zongliang;
Yang, Nian;
Xu, Long;
Lu, Huaqing;
Chen, Yongdong;
Wang, Zeng;
Lu, Qizhong;
Zhong, Kunhong;
Zhu, Zhixiong;
Wang, Guoqing;
Li, Hexian;
Zheng, Meijun;
Zhou, Liangxue;
Tong, Aiping

Publication type:

Article

Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03755-w

By:

Abdulrahman, Ziena;
Kortekaas, Kim E.;
Welters, Marij J. P.;
van Poelgeest, Mariette I. E.;
van der Burg, Sjoerd H.

Publication type:

Article

High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03754-x

By:

Eric, Hjalmarsson;
Piersiala, Krzysztof;
Lagebro, Vilma;
Farrajota Neves Da Silva, Pedro;
Petro, Marianne;
Starkhammar, Magnus;
Elliot, Alexandra;
Bark, Rusana;
Margolin, Gregori;
Kumlien Georén, Susanna;
Cardell, Lars-Olaf

Publication type:

Article

In vitro CAR-T cell killing: validation of the potency assay.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03753-y

By:

Piccinini, Claudia;
Carloni, Silvia;
Arienti, Chiara;
Pancisi, Elena;
Fanini, Francesca;
Pignatta, Sara;
Soldati, Valentina;
Stefanelli, Monica;
Granato, Anna Maria;
Martinelli, Giovanni;
Ridolfi, Laura;
Petrini, Massimiliano

Publication type:

Article

GSDME-mediated pyroptosis promotes anti-tumor immunity of neoadjuvant chemotherapy in breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03752-z

By:

Fu, Changfang;
Ji, Wenbo;
Cui, Qianwen;
Chen, Anling;
Weng, Haiyan;
Lu, Nannan;
Yang, Wulin

Publication type:

Article

A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)<sup>+</sup>/CD141 (BDCA-3)<sup>+</sup> myeloid dendritic cells in solid tumors

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03751-0

By:

Vounckx, Manon;
Tijtgat, Jens;
Stevens, Latoya;
Dirven, Iris;
Ilsen, Bart;
Vandenbroucke, Frederik;
Raeymaeckers, Steven;
Vekens, Karolien;
Forsyth, Ramses;
Geeraerts, Xenia;
Van Riet, Ivan;
Schwarze, Julia Katharina;
Tuyaerts, Sandra;
Decoster, Lore;
De Ridder, Mark;
Dufait, Ines;
Neyns, Bart

Publication type:

Article

Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03749-8

By:

Li, Zhilang;
Ma, Lisha;
Gao, Zhaoya;
Wang, Xiya;
Che, Xuan;
Zhang, Pengchong;
Li, Yixian;
Zhang, Qianjing;
Liu, Tianxing;
Sun, Yuan;
Bai, Yun;
Deng, Hongkui

Publication type:

Article

The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03748-9

By:

Xie, Qingjian;
Zeng, Yuan;
Zhang, Xiangting;
Yu, Fujun

Publication type:

Article

Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03746-x

By:

Stayoussef, M.;
Weili, X.;
Habel, A.;
Barbirou, M.;
Bedoui, S.;
Attia, A.;
Omrani, Y.;
Zouari, K.;
Maghrebi, H.;
Almawi, W. Y.;
Bouhaouala-Zahar, B.;
Larbi, A.;
Yacoubi-Loueslati, B.

Publication type:

Article

Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03740-3

By:

El-Serafi, Ibrahim;
Micallef Nilsson, Isabella;
Moter, Alina;
Duan, Zhe;
Mattsson, Jonas;
Magalhaes, Isabelle

Publication type:

Article

Differences in the risk of immune-related pneumonitis between PD-1 and PD-L1 inhibitors: a meta-analysis according to the new mirror-principle and PRISMA guidelines.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03736-z

By:

Tian, Yuan;
Yin, Zongxiu;
Zhang, Chi;
Li, Zhuoqi;
Wang, Yuanyuan;
Zhang, Kai;
Chen, Feng;
Dang, Qi

Publication type:

Article

Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03709-2

By:

Liu, Shijin;
Wang, Penglin;
Wang, Peize;
Zhao, Zhan;
Zhang, Xiaolin;
Pan, Yunlong;
Pan, Jinghua

Publication type:

Article

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03741-2

By:

Messina, Carlo;
Catalano, Martina;
Roviello, Giandomenico;
Gandini, Annalice;
Maruzzo, Marco;
De Giorgi, Ugo;
Pedrazzoli, Paolo;
Sbrana, Andrea;
Zucal, Paolo Andrea;
Masini, Cristina;
Naglieri, Emanuele;
Procopio, Giuseppe;
Milella, Michele;
Catalano, Fabio;
Fratino, Lucia;
Pipitone, Stefania;
Ricotta, Riccardo;
Panni, Stefano;
Mollica, Veronica;
Soraru, Mariella

Publication type:

Article